There are a number of important issues regarding neoadjuvant and adjuvant therapy for pancreatic cancer that must be considered as we design clinical trials in an effort to improve survival for this disease.
Vincent Vinciguerra, MD
Advertisement
Articles by Vincent Vinciguerra, MD
Advertisement
Latest Updated Articles
- Adjuvant and Neoadjuvant Therapy for Pancreatic Cancer
Published: February 18th 2011 | Updated:
Advertisement
Advertisement
Trending on CancerNetwork
1
AI-Powered Scout Platform Could Enhance Oncology Decision-Making With Data- and Expert-Driven Insights
2
FDA Grants Interchangeability Designation to 2 Denosumab Biosimilars
3
Sac-TMT Combo Produces Encouraging Activity in Pretreated Metastatic CRPC
4
Molecular Insights Into Cancer Cachexia: An Evolution in Identifying the Syndrome
5
